Resume Doctor Alon Shrim

December 2015

Alon Shrim, MD
Date and place of birth: January 17, 1966; Tel Aviv, Israel
Marital status: married + 4
Additional personal details:
Clinic: 34 Habarzel St. Tel Aviv. Building A, 3rd floor. Phone 050-454-8448
Work Address: Department of Obstetrics and Gynecology, Hillel Yaffe Medical Center, POB 169, Hadera, Israel
Tel.: 077-5352495; Mobile: 050-6246988; Fax: 04-6188225 e-mail: dr.shrim@gmail.com

.Tel Aviv clinic: 34 HaBarzel St. Entrance A, 3rd floor
.Hadera clinic: 11 Hillel-Yaffe St 

1. PERSONAL DETAILS

דף הבית > מידע נוסף > RESUME
1995 BMedSc, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
1998 MD, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel 

2. ACADEMIC DEGREES

2013 to present Clinical Assistant Professor, Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel
2008 – 2011 Assistant Professor, Faculty of Medicine, McGill University, Montreal Canada

3. ACADEMIC APPOINTMENTS

2011 to present Director of Ultrasound, Department of Obstetrics and Gynecology, Hillel Yaffe Medical Center, Hadera, Israel
2008 – 2011 Staff Perinatologist, Consultant, Assistant Professor, Division of Maternal Fetal Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada
2006 – 2008 Staff Perinatologist, Head of MFM (Maternal Fetal Medicine) Pharmacology, Maternal Fetal Medicine Division, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel 
2005 – 2006 Clinical Fellowship, MFM and Maternal Fetal Pharmacology and Toxicology Program, Hospital for Sick Children, “Motherisk” program, and Mount Sinai Hospital, University of Toronto, Toronto, Canada 
2004 – 2005 Clinical Fellowship, High Risk Obstetrics and Maternal Fetal Pharmacology & Toxicology, Mount Sinai Hospital, Toronto, Canada
2004 Physician, High-Risk Pregnancies Clinic, Maccabi (HMO) medical services, Balfur Clinic, Tel Aviv, Israel 
2004 Israeli Board Certification in Obstetrics Gynecology and Infertility 
2002 Elective Resident, Ultrasound Unit, Department of Obstetrics and Gynecology Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel 
1998 – 2004 Resident, Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel
1997 Intern, rotating internship, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel

4. PROFESSIONAL EXPERIENCE

 Prenatal ultrasound
 Maternal fetal medicine
 Quality assurance in obstetrics
 Multi-fetal pregnancies

5. RESEARCH INTERESTS

Clerkships
1998 – 2006 Teaching three groups of medical students in Obstetrics and Gynecology clerkships, Sackler Medical School, Tel Aviv University, Tel Aviv, Israel
2004 Main tutor of medical students in Obstetrics and Gynecology clerkship, Sackler Medical School, Tel Aviv University, Tel Aviv, Israel
2008 – 2011 Teaching medical students and Ob/Gyn residents during Obstetrics and Gynecology clerkships and ultrasound/MFM clerkships, Faculty of Medicine, McGill University, Montreal, Canada 
2009 Research clerkship, supervision of Ob/Gyn resident, Ola Malabarey., McGill University, Montreal, Canada, “Risk factors for post-partum hemorrhage in low risk patients” 
2010 Research clerkship, supervision of Ob/Gyn resident, Karen Wou, McGill University, Montreal, Canada, “Pregnancy outcomes and ultrasonographic diagnosis in patients with histologically-proven placental Chorioangioma” 
2010 Research clerkship, supervision of Ob/Gyn resident, Fahad Algreisy. McGill University, Montreal, Canada, “Obstetric outcome in pregnancies with extremely long and short umbilical cord” 
2010 Research clerkship, supervision of Ob/Gyn resident, Senem Ates, McGill University, Montreal, Canada, “Is young maternal age really a risk factor?” 
2010 Research clerkship, supervision of medical student, Lauren McGruthers, McGill University, Montreal, Canada, in combination with Ziv Medical Center, Safed, Israel, “Rhinosinositis quality of life during pregnancy”
2011 Research clerkship, supervision of Ob/Gyn resident, Nimrah Abbasi, McGill University, Montreal, Canada, “Rates of detection and obstetric outcome in pregnancies with single umbilical artery”
2011 Research clerkship, supervision of medical student, Jessica Pearsall. McGill University, Montreal, Canada, “Natural outcome of low laying placenta” 
2012 – 2015 Teaching and supervision of Technion students Israel as part of Ob/Gyn rotation at Hillel Yaffe Medical Center, Rappaport Faculty of Medicine, Haifa 

6. TEACHING EXPERIENCE

2015 Lecturer in Continuous Medical Education studies on “pre-eclampsia prediction and prevention, mainly using ultrasound”
2015 Examiner/evaluator in one-day assessment for potential candidates for Rappaport Faculty of Medicine

7. FACULTY ACTIVITIES

Assigned Reviewer in Peer Reviewed Journals
1. European Journal of Obstetrics & Gynecology and Reproductive Biology
2. Journal of Perinatal Medicine
3. Indian Journal of Medical Research
4. International Journal of Gynecology and Obstetrics
5. Fertility & Sterility

8. PUBLIC PROFESSIONAL ACTIVITIES

לקביעת תור 072-3304240
לד"ר אלון שרים 050-6246988

צור קשר

INTERNATIONAL
006 – 2015 Society of Obstetricians and Gynecologists of Canada (SOGC) 2008 – 2011 College des Medecins du Quebec 2008 – 2011 Quebec Medical Association

NATIONAL
1998 – 2015 Israel Obstetrics and Gynecology Association 1999 – 2015 Israel Medical Association 2008 – 2015 Israel Association for Ultrasound in Obstetrics and Gynecology

9. MEMBERSHIP IN PROFESSIONAL SOCIETIES

2004 “Best Tutor,” students clerkship, Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

2010 Carl Nimrod Educator Award for outstanding achievements and excellence in teaching in Ob-Gyn, Association of Academic Professionals in Obstetrics and Gynecology in Canada

2015 “Best Lecturer,” Rappaport Faculty of Medicine, Technion – Israel Institute of Technology

10. HONORS

MD Theses
COMPLETED
Dr. Yael Yagur, MD. “Detection of risk factors for fetal anomalies in a rural hospital population.” Rappaport Faculty of Medicine, Technion – Israel Institute of Technology (Co-Supervisor: Prof. Motti Hallak).
Research Clerkships
COMPLETED
2008 – 2011 Fahad Algreisy, Senem Ates, Ola Malabarey, Nimrah Abbasi and Karen Wou, Department of Ob/Gyn, McGill University, Montreal, Canada
2010 – 2011 Jessica Pearsall and Lauren McGruthers, McGill University, Montreal, Canada 

11. GRADUATE STUDENTS

2005 – 2006 Restracomp Hospital for Sick Children Research Training Center (RTC) grant, $70,000, Safety of vitamin B6 for nausea and vomiting in pregnancy. PI: Alon Shrim.

2010 Alva Foundation Grant in Neonatal and Newborn Health, Society of Obstetricians and Gynecologists of Canada – SOGC, $40,000, Maternal 6 predictors of RBC folate levels in an urban Canadian population. Coinvestigator: Jennifer Snyder, McGill University.

12. RESEARCH GRANTS

2008 – 2011 Director of “More (Managing Obstetrical Risk Effectively) Ob” program, McGill University Health Center (professional development and performance improvement program), Montreal, Canada

13. SIGNIFICANT PROFESSIONAL PROJECTS

Thesis
1998 MD thesis: Complications of cataract surgery in patients with high myopia. Supervisor: Prof. Ehud Assia
Refereed Papers in Professional Journals
CLINICAL DESCRIPTIVE RESEARCH
1. Soriano D, Shrim A, Seidman D, Goldenberg M, Mashiach S, Oelsner G. Diagnosis and treatment of heterotopic pregnancy a compared with ectopic pregnancy. Journal of the American Association of Gynecologic Laparoscopists 2002 Aug; 9(3):349-354.

2. Elizur SE, Levron J, Shrim A, Sivan E, Dor J, Shulman A. Monozygotic twinning is not associated with zona pellucida micromanipulation procedures but increases with high-order multiple pregnancies. Fertility and Sterility 2004 Aug; 82(2):500-501.

3. Beiner ME, Gotlieb WH, Korach Y, Shrim A, Stockheim D, Segal Y, Fridman E, Ben-Baruch G. Cystectomy for immature teratoma of the ovary. Gynecologic Oncology 2004 May; 93(2):381-384.

4. Shrim A, Koren G. Anti tumour necrosis factor alpha and use of infliximab. Safety during pregnancy. Canadian Family Physician 2005; 51:667-668.

5. Wiser A, Levron J, Kreizer D, Achiron R, Shrim A, Sciff E, Dor J, Shulman A. Outcome of pregnancies complicated by severe ovarian hyperstimulation syndrome (OHSS): a follow-up beyond the second trimester. Human Reproduction 2005; 20(4):910-914.

6. Weisz B, Shrim A, Homko C, Schiff E, Epstein GS, Sivan E. One vs. two hours post- 7 prandial glucose measurement in gestational diabetes – a prospective study. Journal of Perinatology 2005 Apr; 25(4):241-244.

7. Shrim A, Boskovic R, Maltepe C; Navios Y, Garcia Bournissen F, Koren G. The safety of higher than usual vitamin B6 in pregnancy. J Obstet Gynaecol. 2006 Nov; 26(8):749-751.

8. Garcia-Bournissen F, Shrim A, Koren G. The safety of gadolinium in pregnancy. Canadian Family Physician 2006; 52:309-310.

9. Magee L, Shrim A, Koren G. Diagnosis and management of nausea and vomiting in pregnancy. Fetal and Maternal Medicine Review 2006; 17(1)45-67.

10. Shrim A, Elizur S, Seidman D, Dor J. Elevated FSH/LH ratio in the presence of normal FSH levels predicts poor ovarian response. Reproductive Biomedicine Online 2006; 12(4):418-422.

11. Garcia-Bournissen F, Shrim A, Koren G. Exposure to sibutramine during pregnancy. Canadian Family Physician 2007 Feb; 53(2):229-230.

12. Meirow D, Dor J, Kaufman B, Shrim A, Rabinovici J, Schiff E, Raanani H, Levron J, Fridman E. Cortical fibrosis and blood vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Human Reproduction 2007 Jun; 22(6):1626-1633.

13. Shrim A, Farine D, Koren G: When pregnant women are not screened for HIV. Canadian Family Physician 2007 Oct; 53(10):1663-1665.

14. Shrim A, Levin I, Mallozzi A, Brown R, Salama K, Gamzu R, Almog B. Does very advanced maternal age, with or without egg donation, really increase obstetric risk in a large tertiary center? Journal of Perinatal Medicine 2010; 38(6): 645-650.

15. Wagman I, Levin I, Kapustiansky R, Shrim A, Amit A, Almog B, Azem F. Clomiphene citrate vs. letrozole for cryopreserved-thawed embryo transfer: a randomized, controlled trial. Journal of Reproductive Medicine 2010; 55(3-4):134- 138.

16. Shrim A, Weisz B, Gindes L, Gagnon R. Parameters associated with outcome in third trimester monochorionic diamniotic twin pregnancies. Journal of Obstetrics and Gynaecology Canada 2010 May; 32(5):429-434.

17. Shrim A, Weisz B, Gindes L, Dulitzki M, Almog B. Preferences of caregiver when experiencing nausea and vomiting during pregnancy. Journal of Reproductive Medicine 2010 Mar; 38(2):157-160. 8

18. Weisz B, Hogen L, Gindes L, Yinon Y, Shrim A, Simchen A, Schiff A, Lipitz S. Perinatal outcome of monochorionic twins with selective IUGR compared with uncomplicated monochorionic twins. Twin Research and Human Genetics 2011 Oct;14(5):457-62.

19. Weisz B, Book M, Lipitz S, Katorza E, Achiron R, Grossman Z, Shrim A. Fetal outcome and amniocentesis results in pregnancies complicated by varicella infection. Journal of Obstetrics and Gynaecology Canada 2011; 33(7):720-724.

20. Wou K, Chen MF, Mallozzi A, Brown RN, Shrim A. Pregnancy outcomes and ultrasonographic diagnosis in patients with histologically-proven placental chorioangioma. Placenta 2011; 32(9):671-674.

21. Malabarey O, Almog B, Brown R, Abenhaim HA, Shrim A. Postpartum hemorrhage in low risk population. Journal of Reproductive Medicine 2011; 39(5):495-498.

22. Shrim A, Ates S, Mallozzi A, Brown R, Ponte V, Levin I, Shehata F, Almog B. Is young maternal age really a risk factor for adverse neonatal outcome in a North American tertiary referral hospital? Journal of Pediatric and Adolescent Gynecology 2011; 24(4):218-222.

23. Shehata F, Levin I, Shrim A, Ata B, Weisz B, Gamzu R, Almog B. Placenta/birth weight ratio and perinatal outcome; a retrospective cohort analysis. BJOG: An International Journal of Obstetrics & Gynaecology 2011; 118(6):741-747.

24. Almog B, Shehata F, Aljabri S, Levin I, Shalom-Paz E, Shrim A. Placenta weight percentile curves for singleton and twins deliveries. Placenta 2011 Jan; 32(1):58-62.

25. Brown R, Shrim A, Mallozzi A. Does multi-fetal pregnancy reduction adversely influence intra-uterine growth? Acta Obstet Gynecol Scand. 2013 Mar; 92(3):342-345

26. Weissmann-Brenner A, Weisz B, Achiron R, Shrim A. Can discordance in CRL at the first trimester predict birth weight discordance in twin pregnancies? Journal of Reproductive Medicine 2012 May 13; 40(5):489-493.

27. Hoffmann C, Weisz B, Yinon Y, Hogen L, Gindes L, Shrim A, Sivan E, Schiff E, Lipitz S. Diffusion MRI Findings in monochorionic twin pregnancies after intrauterine fetal death. American Journal of Neuroradiology 2013 Jan; 34(1):212- 216.

28. Gilbey P, McGruthers L, Morency AM, Shrim A. Rhinosinusitis-related quality of life during pregnancy. American Journal of Rhinology & Allergy 2012 Jul; 26(4):283-286. 9

29. Shrim A, Koren G, Yudin MH, Farine D. Management of Varicella infection (chickenpox) in pregnancy. Journal of Obstetrics and Gynaecology Canada 2012 Mar; 34(3):287-292.

30. Malabarey OT, Balayla J, Klam S.L, Shrim A, Abenhaim HA. Pregnancies in young adolescent mothers: a population-based study on 37 million births. Journal of Pediatric and Adolescent Gynecology 2012 Apr; 25(2):98-102.

31. Gindes L, Weissmann-Brenner A, Zajicek M, Weisz B, Shrim A, Tzadikevitch Geffen K, Mendes D, Kuint J, Berkenstadt M, Achiron R. Three-dimensional ultrasound demonstration of the fetal palate in high-risk patients: the accuracy of prenatal visualization. Prenatal Diagnosis 2012 Dec; 33(7):E25-30.

32. Zajicek M, Achiron R, Weisz B, Shrim A, Gindes L. Sonographic assessment of fetal secondary palate between twelve and sixteen weeks of gestation using threedimensional ultrasound. Prenatal Diagnosis 2013 Dec; 33(13):1256-1259.

33. Weisz B, Hoffmann C, Ben-Baruch S, Yinon Y, Gindes L, Katorza E, Shrim A, Bar Yosef O, Schiff E, Lipitz S. Early detection of severe brain lesions after fetoscopic laser treatment in twin-twin transfusion syndrome by diffusion weighted sequence MRI. Ultrasound in Obstetrics and Gynecology 2014 Jul; 44(1):6-7.

34. Mei-Dan E, Walfisch A, Weisz B, Hallak M , Brown R, Shrim A. The unborn smoker: association between smoking during pregnancy and adverse perinatal outcomes. Journal of Perinatal Medicine 2015 Sep 1; 43(5):553-558.

35. Walfisch A, Brown R, Mallozzi A, Hallak M, Shrim A. Maternal characteristics of pregnancies with intrauterine fetal demise. Journal of Reproductive Medicine 2015 Jun 30. pii: /j/jpme.ahead-of-print/jpm-2015-0135/jpm-2015-0135.xml. doi: 10.1515/jpm-2015-0135. [Epub ahead of print].

36. Shrim A, Kapur B, Snyder J, Basso O, Blank D, Brown RN. Maternal predictors of RBC folate levels in an urban Canadian population. Reproductive Toxicology 2015; 53:127-130.

37. Sciaky-Tamir Y, Shrim A, Brown RN. Prolonged second stage of labour and the risk for subsequent preterm birth. Journal of Obstetrics and Gynaecology Canada 2015; 37(4):324-329.

Case Reports

1. Shrim A, Berger H, Kingdom J, Hamoudi A, Shah PS, Koren G. Prolonged exposure 10 to angiotensin-converting enzyme inhibitors during pregnancy. Fetal toxicity could be reversible. Canadian Family Physician 2005; 51:1335-1337.

2. Shrim A, Garcia-Bournissen F, Maxwell C, Farine D, Koren G. Favorable pregnancy outcome while taking Herceptin (Trastuzumab) in pregnancy – case report and a literature review. Reproductive Toxicology 2007 Jun; 23(4):611-613.

3. Shrim A, Garcia-Bournissen F, Maxwell C, Farine D, Koren G. Trastuzumab treatment for breast cancer during pregnancy. Canadian Family Physician 2008 Jan; 54(1):31-32.

4. Shrim A, Podymow T, Breech L, Dahan MH. Term delivery in a patient with Cloacal malformation treated by in vitro fertilization. Journal of Obstetrics and Gynaecology Canada 2011; 33(9):952-954.

5. Zeinab AR, Kessel B, Mahamid A, Gazmawi J, Shrim A, Nachtigal A, Alfici R. Computed tomographic diagnosis of traumatic fetal subdural hematoma. Emergency Radiology 2013 Apr; 20(2):169-172.

6. Shrim A, Raviv S, Weisz B, Perri T,Korach J, Hallak M, Frisch L. Asymptomatic expulsion of a fetus through cesarean section scar in the presence of invasive placenta previa. Perinatal Medicine 2014; 4(3):1-3.

Review Papers

1. Shrim A, Beiner M, Weisz B, Seidman DS. Prevention of perinatal group B streptococcal disease, a review and revised guidelines. Harefuah 2004; 143:520-524.

2. Shrim A, Elizur SE, Beiner M, Weiser A. Aromatase inhibitors – new applications in gynecology. Harefuah 2004; 143(8):580-584.

3. Shrim A, Garcia Bournissen F, Koren G. Pharmaceutical agents and pregnancy in urology practice. Urologic Clinics of North America 2007 Feb; 34(1):27-33 (invited review).

4. Walfisch A, Beloosesky R, Shrim A, Hallak M. Adhesion prevention post Cesarean delivery - evidence, and lack of it. American Journal of Obstetrics & Gynecology 2014 Nov; 211(5):446-452.

Books and Book Chapters

1. Shrim A, Seidman DS. Uterine Factors: Which should be remedied before IVF? In: Gynecological Endoscopy and Infertility. Editors: Allahbadia GN, Merchant R, 11 Verhoeven HC, De Wilde RL. Jaypee Brothers Medical Publishers, New Delhi, 2005. pp. 256-266.

2. Shrim A, Dor J. Coasting in Infertility treatments. In: Gynecological Endoscopy and Infertility. Editors: Allahbadia GN, Merchant R, Verhoeven HC, De Wilde RL. Jaypee Brothers Medical Publishers, New Delhi, 2005. pp. 665-680.

3. Ghandi S, Geist R, Shrim A. Maternal disorders leading to increased reproductive risks. In: Maternal Disorders in Pregnancy Medication Safety during Pregnancy and Breastfeeding. (Vol. 1 Part 1: Maternal Fetal Toxicology). Editor: Gideon Koren. Publisher: McGraw-Hill. Toronto, 2006. Chapter 17.

4. Shrim A. Maternal disorders leading to increased reproductive risks. In: Medication Safety in Pregnancy and Breastfeeding. Editor: Gideon Koren. Published by McGraw-Hill Professional, 2007.

5. Shrim A, Lipitz S. Fetal anemia – approach and intrauterine management. In: Ob/Gyn Textbook for Tel Aviv University Resident. Tel Aviv University 2009. pp. 273-286.

6. Wo BL, Mallozzi A, Shrim A. Non obstetrical interventions during pregnancy. In: Cancer in Pregnancy & Lactation: The Motherisk Guide. Cambridge University Press. December 2011.

Letters to the Editor

1. Walfisch A, Shrim A, Hallak M. Can the practice of nonclosure of visceral and parietal peritoneum during cesarean delivery be justified? Reply. American Journal of Obstetrics & Gynecology 2015 Apr; 212(4):550-551.

Non Peer-Reviewed Articles

1. Shrim A, Weisz B. Two fetuses, one placenta. Haaretz Journal, Israel, 2007. http://www.haaretz.co.il/hasite/spages/887187.html

2. Shrim G, Shrim A. The relation between periodontal medicine and preterm labor. Haaretz Journal, Israel, 2007.

3. Shrim A, Weisz B. To perform or not to perform? – amniocenthesis. Haaretz Juornal Israel, 2007.

4. Shrim A, Shalom Paz E. The relation between REI and congenital malformations. Haaretz Journal, Israel 2012 http://www.haaretz.co.il/news/health/1.1733082

14. PUBLICATIONS

Plenary, Keynote or Invited Talks
INTERNATIONAL

1. Angle of progression. Université de Sherbrooke , Quebec, Canada, February 2010.

NATIONAL

1. Caesarean section niche – sonographic diagnosis. Ian Donald course in ultrasound. Tel Aviv, January 2013.

2. Termination of pregnancy in the peri-viable period. Seminar in ethics. The Israeli Society for Maternal & Fetal Medicine, Tel Aviv. March 2013.

Contributed Talks and Abstracts (corresponding author only)

1. Shrim A. Diagnosis and treatment of heterotopic pregnancy a comparative study. The Israeli Society of Gynecologic Endoscopy, Dead Sea, Israel, 2001 (oral presentation).

2. Shrim A. One vs. two hours post-prandial glucose measurement in gestational diabetes – a prospective study. SMFM Annual Meeting, Reno Navada, 2001 (poster presentation).

3. Shrim A. Elevated FSH/LH ratio in the presence of normal FSH levels predict poor ovarian response. ASRM Annual Meeting, Seattle, Washington, 2002 (oral presentation).

4. Shrim A. Is young maternal age really a risk factor for adverse neonatal outcome in a North American tertiary referral hospital? SOGC Annual Meeting, Montreal, Canada, June 2010 (poster presentation).

5. Shrim A. Is late maternal age a risk factor for adverse pregnancy outcomes in twin pregnancies? SOGC annual meeting, Montreal, Canada, June 2010 (poster presentation).

6. Shrim A. Late maternal age as a risk factor for adverse pregnancy outcome in diamniotic dichorionic twin pregnancies. SOGC Annual Meeting, Montreal, Canada, June 2010 (poster presentation).

7. Shrim A. Pregnancy outcomes and ultrasonographic diagnosis in patients with histologically-proven placental chorioangioma. SOGC Annual Meeting, Montreal, Canada, June 2010 (poster presentation). 13

8. Shrim A. Risk factors for post-partum hemorrhage in a low risk population. SOGC Annual Meeting, Vancouver, Canada, June 2011 (oral presentation).

9. Shrim A. Management of retained placenta accreta following vaginal delivery. SOGC Annual Meeting, Vancouver, Canada, June 2011 (poster presentation).

10. Shrim A. Antenatal detection of Single umbilical artery at the routine second trimester anatomy Scan. SOGC Annual Meeting, Vancouver, Canada, June 2011 (poster presentation).

11. Shrim A. Improving patient safety: the intersection of accreditation, stabilized team training and simulation. International Forum on Quality and Safety in Healthcare, Paris, France, April 2012 (poster presentation).

12. Shrim A. Obstetric outcome in patients with long and short umbilical cord. SOGC Annual Meeting, Ottawa, Canada, June 2012 (poster presentation).

13. Shrim A. Placental migration rate in patients with placentas previa and low laying placenta. SOGC Annual Meeting, Ottawa, Canada, June 2012 (poster presentation).

14. Shrim A. Pericenceptional Folate status. Is the right message being transmitted and received? SOGC Annual Meeting, Ottawa, Canada, June 2012 (oral presentation).

15. Shrim A. Are women in Montreal reaching recommended levels of RBC Folate in early pregnancy? SOGC Annual Meeting, Ottawa, Canada, June 2012 (oral presentation).

16. Shrim A. Asymptomatic expulsion of a baby to the maternal abdominal cavity due to invasive placenta. Israeli Association of Maternal Fetal Medicine, Tel Aviv, Israel, November 2013 (poster presentation).

17. Shrim A. Asymptomatic bacteriuria in pregnancy. Two years’ experience of one medical center. Israeli Association of Maternal Fetal Medicine, Tel Aviv, Israel, November 2013 (poster presentation).

18. Shrim A. Trends in termination of pregnancy in women with CMV infection in the 1st trimester of pregnancy. Israeli Association of Maternal Fetal Medicine, Tel Aviv, Israel, November 2013 (poster presentation).

15. CONFERENCES